Verastem (VSTM) Stock
Verastem (VSTM) closed at $8.18 on Nov 13, 2026; its Tenet Score is 18 of 100 against 409 Healthcare peers.
34 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $8.18
- Nov 13, 2026
- Market cap
- $1.0B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 3.43 – 10.82
- low → high
- Tenet Score
- 18/100
- Weak · 409 Healthcare peers
Industry: Drugs · see every company filed here →
Verastem Inc scores 18/100. Weak. Value is the soft spot versus 409 Healthcare peers.
Tenet Score · vs sector
n=409Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✓ Drawdown Context
- ✕ Reversal Evidence
13F flows & insider trades land here.
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Vor Biopharma IncVOR | 49 | $1.2B |
| GH Research PLCGHRS | 59 | $1.2B |
| Harrow IncHROW | 41 | $1.1B |
| Jade Biosciences IncJBIO | 63 | $1.1B |
| Faeth Therapeutics Inc.FTH | 43 | $1.0B |
| Savara IncSVRA | 32 | $1.0B |
| Corvus Pharmaceuticals IncCRVS | 53 | $897.5M |
| MeiraGTx Holdings plcMGTX | 63 | $897.2M |
| 4D Molecular Therapeutics IncFDMT | 53 | $885.3M |
| Pharming Group N.V.PHAR | 41 | $884.1M |
Common questions
What sector and industry is Verastem in?
Verastem is in the Healthcare sector and the Drugs industry.
What is Verastem's Tenet Score?
Verastem's Tenet Score is 18 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.




